Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine assay in chorionic tumors.

D P Goldstein

    Clinical Obstetrics and Gynecology
    |December 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Gestational chorionic tumors are rare, genetically mixed, and highly responsive to chemotherapy. Human chorionic gonadotropin (hCG) serves as a crucial tumor marker for diagnosis and monitoring, offering insights for other cancer types.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development and validation of a clinical prediction-score model for distant metastases in major salivary gland carcinoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.

    Current oncology (Toronto, Ont.)·2019
    Same author

    HPV Status Improves Classification of Head and Neck Gray Zone Cancers.

    Journal of dental research·2019
    Same author

    A dvances in understanding of molar pregnancy.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
    Same author

    Therapeutic protocols for FIGO Stages of GTD.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
    Same author

    Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy.

    Current oncology (Toronto, Ont.)·2017
    Same journal

    Obstetric Care for Patients With Cognitive Disabilities.

    Clinical obstetrics and gynecology·2026
    Same journal

    Dissecting the Americans With Disabilities Act (ADA) Requirements when Approaching Obstetric Patients With Disabilities: How to Ensure Your Spaces are Accessible for All.

    Clinical obstetrics and gynecology·2026
    Same journal

    Clinician Comfort and Barriers to the Obstetric and Gynecologic Care of Patients With Disabilities.

    Clinical obstetrics and gynecology·2026
    Same journal

    Obstetric Care for Patients With Visual Impairments: Preconception Counseling Through Postpartum Care.

    Clinical obstetrics and gynecology·2026
    Same journal

    Menstrual Management and Contraception for Patients With Disabilities.

    Clinical obstetrics and gynecology·2026
    Same journal

    Favoring Elective Hospitalization in Pregnancies With Vasa Previa.

    Clinical obstetrics and gynecology·2026
    See all related articles

    Area of Science:

    • Oncology
    • Endocrinology
    • Genetics

    Background:

    • Gestational chorionic tumors are a unique biological system due to their mixed genetic origin and high chemotherapy responsiveness.
    • These tumors consistently secrete human chorionic gonadotropin (hCG), a reliable marker for diagnosis, treatment monitoring, and remission follow-up.

    Purpose of the Study:

    • To highlight the significance of endocrine assays, particularly hCG measurement, in managing patients with chorionic tumors.
    • To explore the potential of utilizing specific tumor markers, like hCG, for other cancer systems.

    Main Methods:

    • Review of clinical experience with gestational and nongestational chorionic tumors.
    • Analysis of the role of human chorionic gonadotropin (hCG) as a diagnostic and monitoring tool.

    Related Experiment Videos

  • Discussion of emerging tumor markers such as alpha-fetoprotein and carcinoembryonic antigen.

    • Main Results:

    • Human chorionic gonadotropin (hCG) is a highly specific and reliable marker for gestational chorionic tumors.
    • Nongestational chorionic tumors share the characteristic of secreting hCG.
    • Existing markers like alpha-fetoprotein and carcinoembryonic antigen are less specific than hCG.

    Conclusions:

    • The management of chorionic tumors relies heavily on endocrine assays, especially hCG measurement.
    • Experience with chorionic tumors provides a model for developing techniques for other cancers using specific cell markers.
    • The identification of reliable tumor markers is expected to improve patient survival rates across various cancer types.